81 patents currently held
162 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
27 more records may belong here and await a decision; they are not counted.
The next term ends in Mar 2033. from the record
Of the 162 now held by other companies, 159 name Insulet Corporation as their current owner, and 3 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2033
Next term end
35
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2033 · High confidence
Also notable
Ends Jun 2037 · High confidence
Also notable
Ends Jan 2037 · High confidence
Also notable
Ends Sep 2037 · High confidence
Also notable
Ends Nov 2037 · High confidence
Also notable
Ends Feb 2035 · High confidence
Also notable
Ends Nov 2034 · High confidence
Also notable
Ends Apr 2038 · High confidence
Dose Measurement System and Method
US 8,817,258
The most cited patent in this portfolio, cited by 216 later US patents, top 5% of utility patents granted in 2014 in our data. Protection runs to 2033.
Liquid Measurement Systems, Apparatus, and Methods Optimized with Temperature Sensing
US 10,255,991
Cited by 77 later US patents, top 5% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2037.
Diabetes Management System
US 10,293,101
Cited by 52 later US patents, top 5% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2037.
Personalizing Preset Meal Sizes in Insulin Delivery System
US 11,229,751
Cited by 19 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2037. A terminal disclaimer caps this term to an earlier patent's.
Medicine Injection and Disease Management Systems, Devices, and Methods
US 10,426,896
Cited by 80 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2037.
Glucagon Administration System and Methods
US 9,629,901
Cited by 63 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Computer-Based Diabetes Management
US 9,833,191
Cited by 59 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Alarms and Alerts for Medication Delivery Devices and Systems
US 11,096,624
Cited by 24 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2038.
Formerly held, still cited
Notable
Ends Oct 2027 · High confidence
Cited by 466 later US patents, top 1% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
now held by Insulet Corporation
Also notable
Ends Nov 2034 · High confidence
Cited by 51 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2034.
now held by Insulet Corporation
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 4, 2027The maintenance fee for Dose Measurement Systems and Methods (US 11,690,959) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
- 2 fees due Apr 1 to 3, 2027 · next Apr 1
- 1 fee due May 7, 2027The maintenance fee for Medicine Injection and Disease Management Systems, Devices, and Methods (US 11,806,514) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
- 1 fee due Jun 19, 2027The maintenance fee for Devices, Systems, and Methods for Estimating Active Medication from Injections (US 11,844,923) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
- 5 fees due Aug 2 to 20, 2027 · next Aug 2
- 2 fees due Sep 5 to 19, 2027 · next Sep 5
- 4 fees due Oct 2 to 16, 2027 · next Oct 2
- 1 fee due Nov 14, 2027The maintenance fee for Liquid Measurement Systems, Apparatus, and Methods Optimized with Temperature Sensing (US 11,984,204) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.
Recent changes
- 4 of the patents on this record were granted since Aug 23, 2026
- 17 terms have ended since Aug 23, 2026
- Nov 14 US 7,776,030 Operating an Infusion Pump System · term ended
- Nov 8 US 8,679,060 Infusion Pump System · term ended
- Nov 8 US 8,430,847 Infusion Pump System · term ended
- Nov 8 US 8,372,039 Infusion Pump System · term ended
- Oct 23 US 10,105,483 Medicine Dispensing Device · lapsed on the fee record
- Oct 16 US D669,167 Controller for an Infusion Pump · term ended
- Oct 16 US D669,166 Infusion Pump Unit · term ended
- Oct 16 US D669,165 Infusion Pump · term ended
- Oct 3 US 7,938,803 Dispensing Fluid from an Infusion Pump System · term ended
- Sep 27 US 7,794,427 Operating an Infusion Pump System · term ended
- Sep 24 US 8,747,369 Dispensing Fluid from an Infusion Pump System · term ended
- Sep 24 US 8,747,368 Dispensing Fluid from an Infusion Pump System · term ended
- Sep 24 US 10,064,993 Dispensing Fluid from an Infusion Pump System · term ended
- Sep 18 US 9,517,301 Operating an Infusion Pump System · term ended
- Sep 18 US 8,480,623 Method for Dispensing Fluid from an Infusion Pump System · term ended
What they patent
The largest of its 35 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,817,258 | Dose Measurement System and Method In force · High confidence | In force | High confidence | |
| US 9,250,111 | Dose Measurement System and Method In force · High confidence | In force | High confidence | |
| US 9,255,830 | Dose Measurement System and Method In force · Medium confidence | In force | Medium confidence | |
| US 9,638,564 | Dose Measurement System and Method In force · Medium confidence | In force | Medium confidence | |
| US 9,642,968 | Dose Measurement System and Method In force · High confidence | In force | High confidence | |
| US 10,190,901 | Dose Measurement System and Method In force · Medium confidence | In force | Medium confidence | |
| US 10,258,743 | Dose Measurement System and Method In force · High confidence | In force | High confidence | |
| US 10,684,156 | Dose Measurement System and Method In force · Medium confidence | In force | Medium confidence | |
| US 10,821,234 | Dose Measurement System and Method In force · High confidence | In force | High confidence | |
| US 11,566,931 | Dose Measurement System and Method In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 81: 162 patents in force now held by others · 39 patents ended · 41 applications pending · 13 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.